3rd Lipid Nanoparticles Development Summit Europe

Kongressthemen
The spotlight continues to shine on lipid nanoparticles as the 'go-to' delivery vehicle, however the demand remains to translate learnings from vaccine LNP-mRNA success into therapeutic applications. Positioned as a delivery vehicle with no ceiling to innovation, drug developers across the field are continuing to progress research to target the previously unreachable and treating the undruggable.

Kongressorganizer (PCO)
Hanson Wade

Anmerkungen
Brochure: https://go.evvnt.com/2504387-3?pid=4832

Speakers: Alexander Kros, Professor, Leiden University, Christian Plank, Chief Technology Officer, Ethris, Daniel Tondera, Head of Biology, Pantherna Therapeutics, and more

https://go.evvnt.com/2504387-1?pid=4832

Frau Emily Semmens